title: Large-cell neuroendocrine cancer of the colon following rituximab-based lymphoma treatment.
authors.affiliation: Department of Medicine, University of Brirish Columbia, Vancouver, British Columbia. hugfree@shaw.ca
authors.forename: Hugh James
authors.initials: HJ
authors.lastname: Freeman
authors.forename: Peter W C
authors.initials: PW
authors.lastname: Kwan
authors.forename: Douglas
authors.initials: D
authors.lastname: Webber
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000628:therapy; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000209:etiology*; D018358:Neuroendocrine Tumors / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D000069283:Rituximab; D013736:Testicular Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone